Vincent Roh

760 total citations
15 papers, 424 citations indexed

About

Vincent Roh is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Vincent Roh has authored 15 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 3 papers in Immunology. Recurrent topics in Vincent Roh's work include Cancer Immunotherapy and Biomarkers (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Lung Cancer Research Studies (2 papers). Vincent Roh is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Lung Cancer Research Studies (2 papers). Vincent Roh collaborates with scholars based in Switzerland, United States and Germany. Vincent Roh's co-authors include Stephan A. Vorburger, Deborah Stroka, Daniel Candinas, Adrian Keogh, Mario P. Tschan, Alexander Laemmle, Genrich V. Tolstonog, Wayne A. Phillips, Karen G. Montgomery and Christian Simon and has published in prestigious journals such as PLoS ONE, Biochemical Journal and Clinical Cancer Research.

In The Last Decade

Vincent Roh

15 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vincent Roh Switzerland 11 231 147 104 71 69 15 424
Diping Wang United States 8 445 1.9× 105 0.7× 86 0.8× 49 0.7× 34 0.5× 13 619
Ya‐Chin Hou Taiwan 12 262 1.1× 199 1.4× 109 1.0× 133 1.9× 22 0.3× 21 508
João Carlos Guedes Sampaio Góes Brazil 7 175 0.8× 168 1.1× 135 1.3× 23 0.3× 21 0.3× 12 381
Samuele Gherardi Italy 13 538 2.3× 176 1.2× 184 1.8× 35 0.5× 62 0.9× 20 730
Kyle M. LaPak United States 6 187 0.8× 113 0.8× 55 0.5× 55 0.8× 12 0.2× 11 353
Vasileios Mourmouras Italy 12 214 0.9× 176 1.2× 54 0.5× 149 2.1× 23 0.3× 17 530
Dolores Mahmud United States 11 242 1.0× 106 0.7× 33 0.3× 93 1.3× 14 0.2× 20 455
Tania Valencia United States 8 380 1.6× 142 1.0× 229 2.2× 61 0.9× 12 0.2× 10 574

Countries citing papers authored by Vincent Roh

Since Specialization
Citations

This map shows the geographic impact of Vincent Roh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Roh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Roh more than expected).

Fields of papers citing papers by Vincent Roh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Roh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Roh. The network helps show where Vincent Roh may publish in the future.

Co-authorship network of co-authors of Vincent Roh

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Roh. A scholar is included among the top collaborators of Vincent Roh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Roh. Vincent Roh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Romero, Jackeline F., Sara Labiano, Andrea Kelemen, et al.. (2025). PD-1 cis-targeted IL-2v in combination with radiotherapy inhibits lung cancer growth and remodels the immune microenvironment. Journal for ImmunoTherapy of Cancer. 13(1). e009832–e009832. 3 indexed citations
2.
Fournier, Marion, et al.. (2024). Reciprocal inhibition of NOTCH and SOX2 shapes tumor cell plasticity and therapeutic escape in triple-negative breast cancer. EMBO Molecular Medicine. 16(12). 3184–3217. 5 indexed citations
3.
Pascual, Justine, Amber D. Bowler, Vincent Roh, et al.. (2023). Bcl-xL targeting eliminates ageing tumor-promoting neutrophils and inhibits lung tumor growth. EMBO Molecular Medicine. 16(1). 158–184. 21 indexed citations
4.
Labiano, Sara, Vincent Roh, Jackeline F. Romero, et al.. (2021). CD40 Agonist Targeted to Fibroblast Activation Protein α Synergizes with Radiotherapy in Murine HPV-Positive Head and Neck Tumors. Clinical Cancer Research. 27(14). 4054–4065. 27 indexed citations
5.
Domingos‐Pereira, Sonia, et al.. (2021). Vaccination with a nanoparticle E7 vaccine can prevent tumor recurrence following surgery in a human papillomavirus head and neck cancer model. OncoImmunology. 10(1). 1912473–1912473. 9 indexed citations
6.
Roh, Vincent, Jean‐Paul Rivals, J Sponarová, et al.. (2019). The transcription factor FOXM1 regulates the balance between proliferation and aberrant differentiation in head and neck squamous cell carcinoma. The Journal of Pathology. 250(1). 107–119. 8 indexed citations
7.
Roh, Vincent, Pierre Abramowski, Kerstin Cornils, et al.. (2018). Cellular Barcoding Identifies Clonal Substitution as a Hallmark of Local Recurrence in a Surgical Model of Head and Neck Squamous Cell Carcinoma. Cell Reports. 25(8). 2208–2222.e7. 29 indexed citations
8.
Mermod, Maxime, Esther Bovay, Vincent Roh, et al.. (2018). Mouse model of postsurgical primary tumor recurrence and regional lymph node metastasis progression in HPV‐related head and neck cancer. International Journal of Cancer. 142(12). 2518–2528. 29 indexed citations
9.
Hare, Lauren, Toby J. Phesse, Paul Waring, et al.. (2013). Physiological expression of the PI3K-activating mutation Pik3caH1047R combines with Apc loss to promote development of invasive intestinal adenocarcinomas in mice. Biochemical Journal. 458(2). 251–258. 18 indexed citations
10.
Tikoo, Anjali, Vincent Roh, Karen G. Montgomery, et al.. (2012). Physiological Levels of Pik3caH1047R Mutation in the Mouse Mammary Gland Results in Ductal Hyperplasia and Formation of ERα-Positive Tumors. PLoS ONE. 7(5). e36924–e36924. 58 indexed citations
11.
Laemmle, Alexander, Vincent Roh, Adrian Keogh, et al.. (2012). Inhibition of SIRT1 Impairs the Accumulation and Transcriptional Activity of HIF-1α Protein under Hypoxic Conditions. PLoS ONE. 7(3). e33433–e33433. 125 indexed citations
12.
Wagner, Markus, Vincent Roh, Alexander Laemmle, et al.. (2009). Effective Treatment of Advanced Colorectal Cancer by Rapamycin and 5-FU/Oxaliplatin Monitored by TIMP-1. Journal of Gastrointestinal Surgery. 13(10). 1781–1790. 17 indexed citations
13.
Jenal, Mathias, Emmanuelle Trinh, Christian Britschgi, et al.. (2009). The Tumor Suppressor Gene Hypermethylated in Cancer 1 Is Transcriptionally Regulated by E2F1. Molecular Cancer Research. 7(6). 916–922. 24 indexed citations
14.
Roh, Vincent, Alexander Laemmle, Urs von Holzen, et al.. (2008). Dual induction of PKR with E2F-1 and IFN-α to enhance gene therapy against hepatocellular carcinoma. Cancer Gene Therapy. 15(10). 636–644. 11 indexed citations
15.
Roh, Vincent, Adrian Keogh, Peter Studer, et al.. (2007). Hypoxia increases cytoplasmic expression of NDRG1, but is insufficient for its membrane localization in human hepatocellular carcinoma. FEBS Letters. 581(5). 989–994. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026